We are live on ! Find out more
Viking Global Investors

Viking Global Investors Portfolio holdings

AUM $35.7B
1-Year Est. Return 21.3%
This Fund
S&P 500
This Quarter Est. Return
+5.57%
1 Year Est. Return
+21.3%
3 Year Est. Return
+91.13%
5 Year Est. Return
+89.39%
10 Year Est. Return
+464.55%
AUM
$30.9B
AUM Growth
+$3.46B
Cap. Flow
+$2.47B
Cap. Flow %
8%
Top 10 Hldgs %
35.93%
Holding
105
New
22
Increased
29
Reduced
26
Closed
19

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$1.08B
2
SCHW
Charles Schwab
SCHW
+$922M
3
INTU icon
Intuit
INTU
+$913M
4
JPM icon
JPMorgan Chase
JPM
+$878M
5
TSM icon
TSMC
TSM
+$791M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.13B
2
WDAY icon
Workday
WDAY
+$799M
3
ADBE icon
Adobe
ADBE
+$687M
4
TEAM icon
Atlassian
TEAM
+$568M
5
PM icon
Philip Morris
PM
+$500M

Sector Composition

Rank Sector Weight
1 Financials 29.43%
2 Technology 19.81%
3 Healthcare 16.68%
4 Consumer Discretionary 10.99%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQH icon
76
Equitable Holdings
EQH
$14B
$36.1M 0.12%
764,323
-2,285,939
-75% -$106M
ORIC icon
77
Oric Pharmaceuticals
ORIC
$1.42B
$35.8M 0.12%
4,431,008
+431,008
+11% +$3.95M
DNA icon
78
Ginkgo Bioworks
DNA
$506M
$35.1M 0.11%
3,577,128
IMVT icon
79
Immunovant
IMVT
$8.45B
$34.9M 0.11%
1,407,290
-913,612
-39% -$25.9M
EWTX icon
80
Edgewise Therapeutics
EWTX
$4.81B
$32.7M 0.11%
1,224,986
-256,160
-17% -$8.16M
LULU icon
81
lululemon athletica
LULU
$14.3B
$31.8M 0.1%
+83,105
New +$27.1M
INBX icon
82
Inhibrx
INBX
$1.36B
$27.5M 0.09%
1,787,705
TRVI icon
83
Trevi Therapeutics
TRVI
$2.54B
$18.1M 0.06%
4,400,000
PONY
84
Pony AI Inc
PONY
$3.68B
$10.6M 0.03%
+739,797
New +$9.84M
PEPG icon
85
PepGen
PEPG
$201M
$5.62M 0.02%
1,482,434
RLYB icon
86
Rallybio
RLYB
$87M
$4.03M 0.01%
524,347
AAPL icon
87
Apple
AAPL
$4.45T
-4,859,142
Closed -$1.13B
ACHC icon
88
Acadia Healthcare
ACHC
$2.9B
-3,701,347
Closed -$235M
AMP icon
89
Ameriprise Financial
AMP
$49.7B
-243,055
Closed -$114M
CBRE icon
90
CBRE Group
CBRE
$42.7B
-1,571,735
Closed -$196M
CCL icon
91
Carnival Corporation Ltd
CCL
$38B
-9,559,560
Closed -$177M
DAWN
92
DELISTED
Day One Biopharmaceuticals
DAWN
-2,558,563
Closed -$35.6M
FCX icon
93
Freeport-McMoran
FCX
$96.4B
-3,140,964
Closed -$157M
LLY icon
94
Eli Lilly
LLY
$1.08T
-152,038
Closed -$135M
LVS icon
95
Las Vegas Sands
LVS
$29.6B
-8,665,215
Closed -$436M
MCD icon
96
McDonald's
MCD
$194B
-1,120,649
Closed -$341M
MMM icon
97
3M
MMM
$94.4B
-840,751
Closed -$115M
RCI icon
98
Rogers Communications
RCI
$19.1B
-2,701,058
Closed -$109M
REGN icon
99
Regeneron Pharmaceuticals
REGN
$82.1B
-49,870
Closed -$52.4M
TSLA icon
100
Tesla
TSLA
$1.31T
-436,272
Closed -$114M

Similar funds

Viking Global Investors's Q4 2024 Portfolio in Review

As of Q4 2024, Viking Global Investors held 105 positions worth $30.9B, up 13% from $27.4B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Viking Global Investors deployed $2.47B of net new capital in Q4 2024, opening 22 new positions and adding to 29 existing holdings. Its largest new stake was UnitedHealth: 1,900,457 shares worth $961M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Adobe, an estimated $687M trimmed.

  • Viking Global Investors's largest Q4 2024 buy was UnitedHealth: 1,900,457 shares worth $961M.
  • Viking Global Investors added most to Charles Schwab in Q4 2024, an estimated $922M increase.
  • Viking Global Investors's biggest Q4 2024 reduction was Adobe, cutting an estimated $687M.
  • Viking Global Investors fully exited Apple in Q4 2024, selling an estimated $1.13B.
  • Viking Global Investors's ten largest holdings make up 36% of its $30.9B portfolio in Q4 2024.
  • Viking Global Investors opened 22 new positions and closed 19 in Q4 2024.
  • Viking Global Investors's portfolio value rose 13% quarter-over-quarter to $30.9B.

Based on Viking Global Investors's 13F filing for Q4 2024, filed 14 Feb 2025.